Dynamic Technology Lab’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Dynamic Technology Lab’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,257	Closed	-$224K	–	1476
2024 Q1	$224K	Buy	+14,257	New	+$219K	0.02%	891
2023 Q4	–	Sell	-10,651	Closed	-$135K	–	1479
2023 Q3	$135K	Buy	+10,651	New	+$147K	0.01%	837
2022 Q4	–	Sell	-10,708	Closed	-$198K	–	1611
2022 Q3	$198K	Sell	10,708 -8,272	-44%	-$130K	0.02%	963
2022 Q2	$250K	Buy	+18,980	New	+$209K	0.03%	831
2020 Q1	–	Sell	-3,600	Closed	-$224K	–	1437
2019 Q4	$224K	Buy	+3,600	New	+$171K	0.04%	794
2019 Q3	–	Sell	-9,174	Closed	-$207K	–	1357
2019 Q2	$207K	Buy	+9,174	New	+$215K	0.03%	800

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Dynamic Technology Lab's DCPH Position: Q2 2024 in Review

Dynamic Technology Lab sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 14,257 shares — an estimated $224K sold.

Dynamic Technology Lab first reported a position in DCPH in Q2 2019 and held it in 6 quarters. The position peaked at $250K in Q2 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Dynamic Technology Lab reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Dynamic Technology Lab sold 14,257 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $224K.
Dynamic Technology Lab first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 6 quarters.
Dynamic Technology Lab's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $250K in Q2 2022.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Dynamic Technology Lab's 13F filing for Q2 2024, filed 15 Aug 2024.